nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cell-free Nucleic Acids as Potential Markers for Preeclampsia
|
Hahn, S. |
|
2011 |
32 |
S1 |
p. S17-S20 4 p. |
artikel |
2 |
Cryogenic and low temperature preservation of human placental villous explants – A new way to explore drugs in pregnancy disorders
|
Huppertz, B. |
|
2011 |
32 |
S1 |
p. S65-S76 12 p. |
artikel |
3 |
Development of early non-invasive markers and means for the diagnosis and progression monitoring of preeclampsia and tailoring putative therapies (project pregenesys 037244)
|
Meiri, H. |
|
2011 |
32 |
S1 |
p. S1-S3 3 p. |
artikel |
4 |
Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants
|
Grimpel, Y.-I. |
|
2011 |
32 |
S1 |
p. S55-S64 10 p. |
artikel |
5 |
Microarray Profiling Reveals That Placental Transcriptomes of Early-onset HELLP Syndrome and Preeclampsia Are Similar
|
Várkonyi, T. |
|
2011 |
32 |
S1 |
p. S21-S29 9 p. |
artikel |
6 |
Placenta-bound and Body Fluid PP13 and its mRNA in Normal Pregnancy Compared to Preeclampsia, HELLP and Preterm Delivery
|
Sammar, M. |
|
2011 |
32 |
S1 |
p. S30-S36 7 p. |
artikel |
7 |
Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia
|
Orendi, K. |
|
2011 |
32 |
S1 |
p. S49-S54 6 p. |
artikel |
8 |
PP13 as a marker of pre-eclampsia: A two platform comparison study
|
Cowans, N.J. |
|
2011 |
32 |
S1 |
p. S37-S41 5 p. |
artikel |
9 |
Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
|
Cetin, I. |
|
2011 |
32 |
S1 |
p. S4-S16 13 p. |
artikel |
10 |
Screening for Pre-eclampsia–Lessons from Aneuploidy Screening
|
Cuckle, H.S. |
|
2011 |
32 |
S1 |
p. S42-S48 7 p. |
artikel |
11 |
Title Page/Editorial Board
|
|
|
2011 |
32 |
S1 |
p. i- 1 p. |
artikel |